Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes.
Della Porta MG, Travaglino E, Boveri E, Ponzoni M, Malcovati L, Papaemmanuil E, Rigolin GM, Pascutto C, Croci G, Gianelli U, Milani R, Ambaglio I, Elena C, Ubezio M, Da Via' MC, Bono E, Pietra D, Quaglia F, Bastia R, Ferretti V, Cuneo A, Morra E, Campbell PJ, Orazi A, Invernizzi R, Cazzola M; Rete Ematologica Lombarda (REL) Clinical Network. Della Porta MG, et al. Among authors: orazi a. Leukemia. 2015 Jan;29(1):66-75. doi: 10.1038/leu.2014.161. Epub 2014 May 20. Leukemia. 2015. PMID: 24935723
Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment.
Barosi G, Mesa RA, Thiele J, Cervantes F, Campbell PJ, Verstovsek S, Dupriez B, Levine RL, Passamonti F, Gotlib J, Reilly JT, Vannucchi AM, Hanson CA, Solberg LA, Orazi A, Tefferi A; International Working Group for Myelofibrosis Research and Treatment (IWG-MRT). Barosi G, et al. Among authors: orazi a. Leukemia. 2008 Feb;22(2):437-8. doi: 10.1038/sj.leu.2404914. Epub 2007 Aug 30. Leukemia. 2008. PMID: 17728787 No abstract available.
Myelodysplastic syndromes.
Orazi A, Czader MB. Orazi A, et al. Am J Clin Pathol. 2009 Aug;132(2):290-305. doi: 10.1309/AJCPRCXX4R0YHKWV. Am J Clin Pathol. 2009. PMID: 19605823 Review.
Standards and impact of hematopathology in myelodysplastic syndromes (MDS).
Valent P, Orazi A, Büsche G, Schmitt-Gräff A, George TI, Sotlar K, Streubel B, Beham-Schmid C, Cerny-Reiterer S, Krieger O, van de Loosdrecht A, Kern W, Ogata K, Wimazal F, Csomor J, Várkonyi J, Sperr WR, Werner M, Kreipe H, Hans-Peter H. Valent P, et al. Among authors: orazi a. Oncotarget. 2010 Nov;1(7):483-496. doi: 10.18632/oncotarget.185. Oncotarget. 2010. PMID: 21317447 Free PMC article. Review.
Myelodysplastic syndromes.
Zhou J, Orazi A, Czader MB. Zhou J, et al. Among authors: orazi a. Semin Diagn Pathol. 2011 Nov;28(4):258-72. doi: 10.1053/j.semdp.2011.08.005. Semin Diagn Pathol. 2011. PMID: 22195404 Review.
322 results